U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.1163C>T (p.Thr388Met) AND not specified

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jul 26, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001580520.14

Allele description [Variation Report for NM_000492.4(CFTR):c.1163C>T (p.Thr388Met)]

NM_000492.4(CFTR):c.1163C>T (p.Thr388Met)

Gene:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.1163C>T (p.Thr388Met)
HGVS:
  • NC_000007.14:g.117542062C>T
  • NG_016465.4:g.81279C>T
  • NM_000492.4:c.1163C>TMANE SELECT
  • NP_000483.3:p.Thr388Met
  • NP_000483.3:p.Thr388Met
  • LRG_663t1:c.1163C>T
  • LRG_663:g.81279C>T
  • LRG_663p1:p.Thr388Met
  • NC_000007.13:g.117182116C>T
  • NM_000492.3:c.1163C>T
  • p.Thr388Met
Protein change:
T388M
Links:
dbSNP: rs143860237
NCBI 1000 Genomes Browser:
rs143860237
Molecular consequence:
  • NM_000492.4:c.1163C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000696822Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Jul 26, 2024)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Citation Link,

SCV001984009Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Feb 2, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

CFTR gene mutations--including three novel nucleotide substitutions--and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease.

Tzetis M, Efthymiadou A, Strofalis S, Psychou P, Dimakou A, Pouliou E, Doudounakis S, Kanavakis E.

Hum Genet. 2001 Mar;108(3):216-21.

PubMed [citation]
PMID:
11354633

Mutations of the CFTR gene in Turkish patients with congenital bilateral absence of the vas deferens.

Dayangaç D, Erdem H, Yilmaz E, Sahin A, Sohn C, Ozgüç M, Dörk T.

Hum Reprod. 2004 May;19(5):1094-100. Epub 2004 Apr 7.

PubMed [citation]
PMID:
15070876
See all PubMed Citations (9)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000696822.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

Variant summary: CFTR c.1163C>T (p.Thr388Met) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00016 in 250946 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in CFTR causing CFTR-Related Diseases (0.00016 vs 0.013), allowing no conclusion about variant significance. c.1163C>T has been reported in the literature as heterozygous in individuals affected with CFTR-Related Diseases including CF, CBAVD/CUAVD, asthma, and in children with positive newborn screening, without strong evidence for causality (example, Schrijver_2016, Dayangac_2004, Akinsal_2018, Tzetis_2001, Bozdogan_2021). These reports do not provide unequivocal conclusions about association of the variant with CFTR-Related Diseases. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect resulted in approximately 86.1% of normal chloride channel conductance relative to wild type (e.g., Bihler_2024). The following publications have been ascertained in the context of this evaluation (PMID: 26990548, 29484681, 33572515, 15070876, 29589582, 26708955, 11354633, 38388235). ClinVar contains an entry for this variant (Variation ID: 495887). Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital, SCV001984009.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024